Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra
Andorra: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 96.0% in 2024. ▬ Flat
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra, 2014–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra stood at 96.0%.
The figure is up 2.1% on the previous year and up 3.2% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra peaked at 98.0% in 2017 and was at its lowest, 92.0%, in 2015.
That places Andorra 15th out of 146 countries with data for 2024, putting it in the top 10%.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra, year by year
| Year | % | Change |
|---|---|---|
| 2014 | 93.0% | — |
| 2015 | 92.0% | -1.1% |
| 2016 | 92.0% | +0.0% |
| 2017 | 98.0% | +6.5% |
| 2018 | 94.0% | -4.1% |
| 2019 | 96.0% | +2.1% |
| 2020 | 96.0% | +0.0% |
| 2021 | 95.0% | -1.0% |
| 2022 | 95.0% | +0.0% |
| 2023 | 94.0% | -1.1% |
| 2024 | 96.0% | +2.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 94.2% | 92.0% | 98.0% | 6 |
| 2020s | 95.2% | 94.0% | 96.0% | 5 |
Countries ranked near Andorra
More health data for Andorra
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,824 deaths per 1,000 people (2090)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age dependency ratio 39.2% (2025)
- Age population, age 06, male, interpolated 293 (2025)
- Age population, age 06, female, interpolated 266 (2025)
- Population, male 51.1% (2025)
- Age dependency ratio, young 16.2% (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Andorra was 96.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Andorra?
- The highest recorded value was 98.0% in 2017.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Andorra?
- The lowest recorded value was 92.0% in 2015.
- How does Andorra rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Andorra ranks 15th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Andorra?
- Over the last ten years it is up 3.2%. The long-run trend across the full record is flat.
- Where does this Andorra data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.